Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease.
Theodorakakou F, Briasoulis A, Fotiou D, Petropoulos I, Georgiopoulos G, Lama N, Kelekis N, Repasos E, Migkou M, Stamatelopoulos K, Dimopoulos MA, Kastritis E.
Theodorakakou F, et al. Among authors: kelekis n.
Hematol Oncol. 2023 Oct;41(4):725-732. doi: 10.1002/hon.3135. Epub 2023 Mar 27.
Hematol Oncol. 2023.
PMID: 36974438